These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20056291)

  • 1. The replication cycle of hepatitis B virus.
    Urban S; Schulze A; Dandri M; Petersen J
    J Hepatol; 2010 Feb; 52(2):282-4. PubMed ID: 20056291
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
    McMillan JS; Shaw T; Angus PW; Locarnini SA
    Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of different PAP domains on hepatitis B virus replication].
    Guo CX; He YW; Peng C; Lei YC; Li WT
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):105-8. PubMed ID: 20196948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro.
    Nakazono K; Ito Y; Wu CH; Wu GY
    Hepatology; 1996 Jun; 23(6):1297-303. PubMed ID: 8675142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
    Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
    Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
    Han J; Pan X; Gao Y; Weil L
    Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors.
    Zhang P; Liu F; Guo F; Zhao Q; Chang J; Guo JT
    Antiviral Res; 2016 Jul; 131():40-8. PubMed ID: 27083116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of hepatitis B virus (HBV) replication using antisense LNA targeting to both S and C genes in HBV].
    Deng YB; Nong LG; Huang W; Pang GG; Wang YF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):900-4. PubMed ID: 20038330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver nanoparticles inhibit hepatitis B virus replication.
    Lu L; Sun RW; Chen R; Hui CK; Ho CM; Luk JM; Lau GK; Che CM
    Antivir Ther; 2008; 13(2):253-62. PubMed ID: 18505176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.
    Amini-Bavil-Olyaee S; Herbers U; Luedde T; Trautwein C; Tacke F
    J Viral Hepat; 2011 Nov; 18(11):804-14. PubMed ID: 20887378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of HBV infection.
    Locarnini S; Zoulim F
    Antivir Ther; 2010; 15 Suppl 3():3-14. PubMed ID: 21041899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.
    Mason A; Theal J; Bain V; Adams E; Perrillo R
    Am J Gastroenterol; 2005 Apr; 100(4):972-6. PubMed ID: 15784044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA.
    Köck J; Nassal M; Deres K; Blum HE; von Weizsäcker F
    J Virol; 2004 Dec; 78(24):13812-8. PubMed ID: 15564489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance in antiviral therapy.
    Locarnini S; Bowden S
    Clin Liver Dis; 2010 Aug; 14(3):439-59. PubMed ID: 20638024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of hepatitis B and delta viruses: appearance of viral mutants.
    Foster GR; Carman WF; Thomas HC
    Semin Liver Dis; 1991 May; 11(2):121-7. PubMed ID: 1887256
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro models for studying hepatitis B virus drug resistance.
    Zoulim F
    Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.